Pierre Fabre Dermo-Cosmetic and Abbott Healthcare Strengthen Their Partnership for the Best French Skincare Ranges in India

MUMBAI, India, February 27, 2015 /PRNewswire/ --

~ Avène Ducray & A-Derma products to re-define care for Indian skin ~ 

Pierre Fabre Group, the 3d largest French pharmaceutical group and the 2nd largest dermo‐cosmetics laboratory in the World and Abbott Healthcare Pvt. Ltd., one of India's largest pharmaceutical & healthcare companies have today announced the renewal of their partnership for commercialisation in India of 3 unique dermo-cosmetic ranges, namely AVÈNE, DUCRAY and A-DERMA.  AVÈNE products are formulated with the unique Avène Thermal Spring Water that runs in the South of France. They specialize in highly sensitive skincare, and are globally recommended for Sensitive, Atopic, Intolerant and Allergy prone skin. DUCRAY is the most medical brand existing on the dermo-cosmetic market and A-DERMA is exclusively formulated with Rhealba® oat cultivated organically in the South of France and offering unique soothing properties. This vast range of products covers Cleansing, Moisturizing, Anti-Ageing, Anti-Acne, Sun Protection, Hyper-pigmentation but also healing for atopic and sensitive skins. Pierre Fabre Dermo-cosmetic ranges promise to fulfil the needs of every skin type in India by offering variants for dry, normal and a combination skin.

"Abbott's partnership with Pierre Fabre shows our commitment to bring to India globally renowned derma-cosmetic formulations.  Its AVÈNE, DUCRAY and A-DERMA globally popular brands addresses multitudes of skin concerns of people with sensitive skin or irritated skin; and preserving health and beauty of normal skin and hair," said Sudarshan Jain, Managing Director of Abbott Healthcare."

"Pierre Fabre's background as a pharmaceutical company specializing in Dermatology in addition with its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbott. In order to fulfil the highest expectations of sensitive or fragile skins, clinical and consumer tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin," added M. Eric Ducournau, Chairman Pierre Fabre Dermo-Cosmetics.

"Commenting on their plans in the Indian market, M. Pierre BEHNAM, Country Head Indian Operation said, "The dermo-cosmetic market in India is fairly new but has a lot of potential. The current market size can be pegged at around 100 million Euros (700 Crores Roupies) within 5 years. We have plans to launch 6 new types of products per year and are therefore confident that our premium brands will be instrumental to convert this potential." 

The entire range of Pierre Fabre Dermo-cosmetics products has been meticulously researched and developed to ensure they offer optimal solutions to today's multiple skin needs particularly in India. Products are available at organized chemist stores across India.

About Pierre Fabre 

Pierre Fabre is the 3rd largest French pharmaceutical group and the 2nd largest dermo-cosmetics laboratory in the world. In 2013, its sales reached €2.008 Billion, with Dermo-Cosmetics revenues accounting for 55% and international for 56%. Founded and its headquarters still based in the South-west of France, Pierre Fabre currently has branches in 44 countries and distribution agreements in over 130 countries.

Covering a continuum of healthcare products, from prescription drugs and consumer health care products (OTC, oral care, natural health) to dermo-cosmetics, Pierre Fabre Laboratories employ over 10,000 people worldwide. In 2013, Pierre Fabre allocated more than 17% of its drug revenues to R&D.

With brands such as Avène, Klorane, Ducray, René Furterer, A-Derma, Galénic, Naturactive, Elgydium, Eludril or Drill, Pierre Fabre Laboratories are market leaders when it comes to skin, hair and oral care products distributed in the French pharmacy channel. Avène Thermal Spring Water is marketed worldwide, and is the leading dermo-cosmetics brand sold in Europe, Japan and China. In oncology, Pierre Fabre achieves 90% of its revenues outside of its home country.

Through the Pierre Fabre Participations holding company, the Pierre Fabre Foundation, a government-recognized public-interest foundation, owns 86% of Pierre Fabre Laboratories. Remaining shares are owned by company employees, amounting to 7%, and through treasury stock.

The French certification group AFNOR has audited Pierre Fabre Laboratories for its corporate social responsibility (CSR) performance at advanced level (AFAQ 26 000).

To find out more, please visit http://www.pierre-fabre.com

About Abbott: 

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 77,000 people.

In India, Abbott has more than 14,000 employees working in manufacturing, research and development, logistics, sales and marketing and is headquartered in Mumbai.

Visit Abbott at http://www.abbott.com and connect with us on Twitter at @AbbottNews.